Table of Contents
Overview
Definition and Scope
Neuropharmacology is defined as the scientific study of how drugs affect cellular function within the nervous system and influence behavior. This field encompasses a broad range of topics, from the manipulation of single neurons to the examination of entire areas of the brain, spinal cord, and peripheral nerves.[2.1] The primary focus of neuropharmacology is on the actions of medications used to treat psychiatric and neurologic disorders, as well as the effects of drugs of abuse.[5.1] The discipline is divided into two main categories: central nervous system (CNS) drugs and peripheral nervous system (PNS) drugs, each of which plays a critical role in understanding the pharmacological effects on various aspects of nervous system functioning.[1.1] Neuropharmacology also aims to elucidate the cellular and molecular actions of drugs on synaptic transmission, providing insights into specific diseases of the nervous system and their treatment.[3.1] Furthermore, neuropharmacology contributes significantly to the fields of psychiatry, neuropsychiatry, and neurology by applying models of receptor-ligand interactions to better understand the underlying mechanisms of these clinical conditions.[4.1] Overall, neuropharmacology serves not only as a means to develop therapeutic interventions but also as a tool for enhancing our understanding of normal nervous system functioning.[5.1]Branches of Neuropharmacology
Neuropharmacology encompasses several branches that focus on different aspects of drug action within the nervous system. One significant branch is the pharmacotherapeutic management of neurological and psychiatric disorders, which primarily relies on the modulation of central nervous system (CNS) neurotransmission through drugs that intervene at chemical synapses. This approach is essential for developing treatments that alleviate symptoms and improve the quality of life for individuals with complex conditions.[8.1] Another critical area within neuropharmacology is the assessment of therapeutic effects versus potential side effects of psychiatric medications. This involves a systematic and collaborative process that tailors medication management to the unique needs and responses of each patient. Understanding the balance between risks and benefits is vital, as adverse effects can significantly influence treatment adherence and outcomes.[12.1] Evaluating side effects can be particularly challenging in mental health settings due to the overlapping nature of psychiatric symptoms and medication side effects.[11.1] Neuropharmacology is a critical field that examines how neurotransmitter systems, particularly dopamine and serotonin, influence addiction and emotional health. Dopamine, a neurotransmitter associated with pleasure and reward, plays a pivotal role in the development and persistence of addiction, although its precise function remains complex and debated.[16.1] When individuals engage in drug use or addictive behaviors, the release of dopamine leads to intense feelings of pleasure, which reinforces these habits.[13.1] Serotonin, another important neurotransmitter, regulates mood, sleep, and appetite, and its imbalance can contribute to various mental health issues.[14.1] Research indicates that maintaining a balance of dopamine and serotonin is essential for emotional well-being, as fluctuations in their levels can significantly affect a person's mental health.[14.1] Understanding the relationship between these neurotransmitters is crucial for developing targeted therapies for addiction and related conditions.[13.1] Furthermore, the principles of pharmacokinetics and pharmacodynamics are foundational in neuropharmacology, influencing the design of neuroactive drugs. Pharmacokinetics studies the absorption, distribution, metabolism, and excretion of drugs, while pharmacodynamics focuses on the relationship between drug concentration and effect. Together, these principles guide the rational dosing and therapeutic benefit of medications used in treating neurological disorders.[21.1] Lastly, the influence of neurotransmitter systems extends to the effects of different classes of drugs, highlighting the importance of understanding these interactions for developing targeted therapies. For instance, cholinergic systems play a significant role in cognition and sleep regulation, while excitatory and inhibitory amino acids, such as glutamate, are also critical in behavioral regulation.[23.1] This comprehensive understanding of neurotransmitter interactions is essential for advancing neuropharmacological treatments.History
Early Developments
Ancient civilizations made significant contributions to the early understanding of medicine and the human body, particularly in the context of the nervous system and its relationship with medicinal substances. Among these, Ancient Egypt demonstrated a notable grasp of early medical practices, linking common ailments to their religious beliefs and often attributing them to harmful demons or ghosts.[55.1] Similarly, the Ancient Greeks excelled in observing the emotional and psychological responses of patients, recognizing the interplay between psychic and somatic conditions. They viewed these as different manifestations of potentially the same illness, although such observations were frequently overlooked in subsequent centuries due to the influence of evolving religious paradigms.[54.1] This historical perspective underscores the importance of ancient medical knowledge, which remains relevant in contemporary discussions of psychiatry and drug therapy. Philosophers and physicians like Alcmaeon, Praxagoras, and Herophilus were pivotal in articulating the relationship between the mind, brain, and body, marking a critical advancement in the understanding of the nervous system.[57.1] Their inquiries into the biological functions of the brain contributed to a more integrated view of health, emphasizing the interconnectedness of mental and physical well-being. This holistic approach was further exemplified by Galen, whose integration of scientific inquiry with practical treatment methods underscored the sophistication of ancient neurological practices.[58.1] In addition to these developments, the philosophical paradigms of ancient medicine, including the Vedic practices and the emergence of Ayurveda, reflected a comprehensive understanding of health that encompassed lifestyle adjustments and spiritual dimensions.[56.1] These early insights into the nervous system and medicinal substances not only shaped the foundations of neuropharmacology but also highlighted the enduring relevance of ancient practices in contemporary medicine.[58.1]Evolution of Neuropharmacological Treatments
The evolution of neuropharmacological treatments has been significantly shaped by advancements in both the understanding of neurochemistry and the development of innovative technologies. The field of neuropharmacology emerged in the 1940s and 1950s, evolving from pharmacology and the recognition of internerve communication, which led to the isolation of neurotransmitters.[48.1] This foundational knowledge has allowed researchers to explore how drugs affect the central nervous system, particularly in the treatment of neurological disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy.[59.1] Technological advancements have played a crucial role in this evolution. The introduction of neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and electroencephalography (EEG), has revolutionized the study of brain activity and the effects of neuropharmacological agents. These technologies enable researchers to observe real-time changes in brain function, providing insights into how drugs interact with specific brain regions.[50.1] For instance, fMRI is utilized in drug development to validate the role of neuropharmacological systems and to evaluate compounds associated with particular disorders.[52.1] Moreover, the integration of multimodal imaging techniques has enhanced the understanding of brain function by allowing researchers to study both spatial and temporal dynamics of brain activity.[51.1] This comprehensive approach has led to significant findings, such as the identification of specific neurotransmitter receptors as targets for new anxiolytic drugs, illustrating the potential for tailored treatments based on neuropharmacological research.[64.1] The impact of neuropharmacology extends beyond treatment improvements; it has fundamentally altered the conceptualization of psychiatric disorders, influencing their diagnosis, categorization, and the methodologies employed in experimental therapeutics.[65.1] As neuropharmacologists continue to investigate the interactions between drugs and the nervous system, ongoing research is expected to further refine treatment protocols and enhance the quality of life for individuals suffering from complex conditions such as depression and schizophrenia.[66.1]Recent Advancements
Emerging Pharmacological Concepts
Recent advancements in neuropharmacology have introduced several emerging pharmacological concepts that are reshaping the landscape of treatment for neurological and psychological disorders. One significant area of focus is the exploration of novel drug targets and the development of innovative drug delivery systems. These advancements aim to address the limitations of conventional therapies and enhance the precision of treatment for neurological disorders.[91.1] The integration of nanotechnology into neuropharmacology has shown promise in improving therapeutic delivery. Nanotherapies, particularly when combined with techniques such as CRISPR/Cas9 or siRNA, offer unique potential for targeted approaches in clinical settings.[99.1] This innovative direction not only enhances the efficacy of treatments but also aims to minimize side effects associated with traditional pharmacological interventions. Recent advancements in neuropharmacology have significantly enhanced our understanding of neurotransmitter systems, particularly classic systems such as serotonin, dopamine, and acetylcholine. In-depth studies have revealed that specific serotonin receptor subtypes may play crucial roles in mood regulation and cognition, which has important implications for the development of new medications targeting these systems.[93.1] Furthermore, the field has witnessed remarkable progress in molecular and cellular neuroscience, leading to a comprehensive examination of neurotransmitters, receptors, and signaling pathways, as well as the intricate processes involved in drug development.[94.1] An emerging circuit-based understanding of psychiatric disorders offers a promising alternative to the traditional trial-and-error approach in treatment application, emphasizing the importance of targeting major circuits and neurotransmitter pathways that are disrupted in various psychiatric conditions.[98.1] This shift towards precision psychiatry highlights the revolutionary potential of brain-circuit-based interventions in the development and clinical application of treatments for psychiatric illnesses.[98.1] Additionally, advancements in brain stimulation techniques, such as deep brain stimulation (DBS), have opened new avenues for treating psychiatric disorders. DBS allows for the precise modulation of brain activity, which has shown potential in alleviating symptoms of major depressive disorder by reversing dysfunctional circuit activity.[97.1]Mechanisms Of Action
Drug-Receptor Interactions
Drug-receptor interactions are fundamental to the field of neuropharmacology, as they significantly influence the efficacy and safety of therapeutic agents. These interactions occur when drugs bind to specific molecular targets known as receptors, which are located on the surface or within cells.[143.1] The binding of neurotransmitters to their receptors can either excite or inhibit neuronal firing, thereby altering cellular metabolism and influencing behavior.[141.1] Neuropharmacologic drugs primarily exert their effects by altering receptor activity on target cells, which is a central concept in understanding their mechanisms of action.[130.1] Most neuropharmacologic agents act at the synaptic transmission level, affecting the release of neurotransmitters and their subsequent binding to receptors on post-synaptic cells.[131.1] This process is crucial for the conduction of action potentials and the overall functioning of the nervous system.[131.1] The study of molecular neuropharmacology has revealed that specific interactions between drugs and neurotransmitter receptors can lead to the development of new treatments. For instance, the identification of various serotonin receptors has facilitated the creation of novel anxiolytics, such as buspirone, which acts as a partial agonist at the 5-HT1A receptor.[142.1] This highlights how understanding the molecular interactions involved in drug-receptor binding can lead to targeted therapeutic strategies. Moreover, advances in biochemical investigations have provided insights into how these interactions can be manipulated to achieve desired therapeutic outcomes. By disrupting the binding process of neurotransmitters to their receptors, researchers can develop drugs that either enhance or inhibit specific neuronal pathways, thereby tailoring treatments to individual patient needs.[140.1] This approach underscores the importance of drug-receptor interactions in the ongoing quest to create safer and more effective neuropharmacological therapies.Applications In Medicine
Neurological Disorders
Neuropharmacology plays a crucial role in the treatment of various neurological disorders, including depression, anxiety, schizophrenia, and Parkinson's disease. These conditions often involve complex interactions within the brain, and current treatments may not always be effective, prompting neuropharmacologists to develop new drugs that target specific neurotransmitter systems and receptors.[192.1] Recent advancements in neuropharmacology have focused on novel drug targets and innovative drug delivery systems, which aim to enhance the efficacy of treatments while minimizing systemic side effects. These advancements are essential for addressing the limitations of conventional drug delivery techniques, allowing for more precise targeting of medications to specific regions within the brain.[206.1] Furthermore, the exploration of growth factors and cytokines has opened new avenues for treating neurological diseases, highlighting the importance of understanding the underlying biological mechanisms.[171.1] The integration of patient-centered approaches in drug development is also gaining traction, emphasizing the need to consider patient perspectives throughout the research process. This approach aims to create therapeutic products that are more aligned with patient needs and preferences, ultimately improving treatment outcomes.[177.1] By systematically incorporating patient feedback, neuropharmacologists can enhance the relevance and effectiveness of new therapies for neurological disorders. The role of neurotransmitters and their receptors is essential in the field of neuropharmacology, as it encompasses a comprehensive examination of these elements along with their signaling pathways and the intricate processes involved in drug development.[191.1] Recent advancements in molecular and cellular neuroscience have significantly enhanced our understanding of the complexities of the brain, highlighting the pharmacological interest in neurotransmission.[190.1] Specific neurotransmitter systems, including those involving GABA-A and glycine receptors, have been shown to influence neurogenesis and brain plasticity, which are critical for recovery from various neurological conditions.[189.1] Neuropharmacologists engage in designing experiments to test how new drug compounds interact with these receptors, which is vital for developing medications that can alleviate symptoms and improve the quality of life for individuals affected by neurological disorders.[192.1]Psychiatric Disorders
Significant advancements in the treatment of psychiatric disorders have mirrored shifts in societal attitudes and scientific understanding. Historically, mental health treatment was often confined to asylums, but the 19th century marked a pivotal shift towards more humane approaches. Pioneers like Philippe Pinel and William Tuke championed the moral treatment of individuals with mental illness, laying the groundwork for modern therapeutic practices [184.1]. This era also saw the emergence of talk therapy, notably through Sigmund Freud's work, which began to reshape the therapeutic landscape [184.2]. The evolution of mental health treatment has been profound, transitioning from ancient stigmatization to modern advancements in psychopharmacology and evidence-based therapies. The 19th century was crucial in recognizing mental health conditions as legitimate medical disorders, leading to the deinstitutionalization movement that promoted community integration over institutional confinement [186.1][186.2]. This shift was bolstered by advancements in psychopharmacology, significantly improving the management of mental health conditions [186.3]. Evidence-based therapies, utilizing scientific research and personalized approaches, have further enhanced treatment effectiveness, offering individuals better outcomes and renewed hope for recovery [186.4]. Today, mental health is acknowledged as a vital aspect of overall well-being, with ongoing efforts to improve access to care and reduce the stigma associated with mental illnesses [187.1]. The integration of personalized treatment optimization in psychiatric care is increasingly recognized for its potential to enhance pharmacotherapy for major psychiatric disorders. This approach incorporates therapeutic drug monitoring, pharmacogenomics, and biomarker testing, essential for tailoring treatment to individual patients. Clinical, genetic, and environmental factors significantly influence the efficacy and tolerability of psychotropic medications, underscoring the importance of personalized strategies in mental health treatment [198.1]. The efficacy of pharmacogenomic testing has far-reaching implications, particularly given the growing burden of mental health disorders on public health systems. By incorporating genomics into the treatment process, there is an opportunity to promote smarter and more sustainable healthcare solutions [199.1]. Despite these advancements, challenges remain, particularly regarding the stigma associated with mental health disorders and the underfunding of mental health services compared to physical health facilities [188.1]. Continued efforts are necessary to enhance public understanding, reduce stigma, and improve access to effective treatments for individuals experiencing psychiatric disorders.Future Directions
Challenges and Opportunities
The integration of nanotechnology into neuropharmacology presents both significant challenges and opportunities. A major challenge is the effective delivery of drugs to the central nervous system (CNS), particularly due to the blood-brain barrier (BBB), which effectively prevents the passage of large molecules and particulates, including many therapeutic agents.[226.1] Despite ongoing advancements in the field, the delivery of drugs for the treatment of neurological disorders remains a significant hurdle.[226.1] However, engineered nanoparticles (NPs), which range from 1 to 100 nm in size, are being actively developed as potential nanocarriers to enhance drug delivery across the BBB.[226.1] This evolving field not only addresses technical and manufacturing challenges but also navigates the regulatory hurdles associated with the formulation of nanoparticle-based therapies.[226.1] Moreover, the complexity of neurological disorders necessitates highly targeted therapies, which can be facilitated by nanotechnology. This technology not only aims to improve the specificity of drug delivery but also seeks to minimize unwanted side effects, thereby enhancing the overall efficacy of treatments.[230.1] However, the development of such targeted therapies is fraught with technical, manufacturing, and regulatory challenges that must be addressed to transition from theoretical applications to practical clinical use.[228.1] The evolution of personalized medicine in neuropharmacology presents both significant challenges and opportunities. Personalized medicine aims to tailor treatments based on individual genetic and biochemical profiles, which is expected to enhance health outcomes within sustainable healthcare systems.[261.1] However, there are considerable barriers to its widespread implementation in clinical practice. A primary challenge is the insufficient understanding of the pathophysiology of many common neurological conditions, such as depression and epilepsy, as well as the mechanisms of existing pharmacological interventions.[258.1] Additionally, practical issues surrounding the implementation of personalized medicine, including resource allocation, infrastructure requirements, and ethical considerations, are often overlooked in contemporary discussions.[260.1] Engaging various stakeholders, including healthcare professionals, policymakers, and patients, is crucial to developing a cohesive strategy for integrating personalized medicine into healthcare systems.[259.1] Furthermore, while genetic factors significantly influence treatment responses, it is essential to consider other factors such as environmental exposures, developmental phenomena, and behavioral aspects when determining optimal treatment approaches for individual patients.[262.1] Despite these challenges, the potential for personalized medicine to revolutionize neuropharmacology is substantial. Advances in genomic science and molecular innovations are driving the pharmaceutical industry to move beyond traditional broad-spectrum therapies towards more individualized treatment strategies.[263.1] This shift could ultimately lead to more effective interventions that are better suited to the unique characteristics of each patient, thereby enhancing therapeutic outcomes in the field of neuropharmacology.Potential Research Areas
Advancements in neuropharmacology are increasingly focused on novel drug targets and innovative delivery systems to address the complexities of neurological disorders. Research is exploring novel drug delivery systems that aim to efficiently and precisely target medications to specific regions within the brain, which is crucial for developing effective treatments for neurological conditions.[216.1] Neuropeptides have emerged as a highly active area of research in neurobiology and neuropharmacology, highlighting the need to update existing data in light of the evolving understanding of glial cells' roles in the nervous system's physiology and pathology.[219.1] Furthermore, recent advances in molecular neuropharmacology have identified potential therapeutic targets for Alzheimer's disease (AD), a significant neurodegenerative challenge characterized by profound cognitive decline, thus offering renewed hope for effective disease-modifying therapies.[218.1] Moreover, the integration of neurotechnology is anticipated to significantly influence treatment protocols for neuropsychiatric disorders. This includes the development of advanced imaging technologies, drug delivery systems, and neuromodulation platforms that promise to enhance treatment efficacy.[223.1] The OECD has identified systemic changes necessary for accelerating neurotechnology developments, emphasizing responsible research and open innovation to foster collaboration among stakeholders.[224.1] Artificial intelligence (AI) and machine learning (ML) are also emerging as pivotal tools in drug discovery for neurological disorders. These technologies facilitate the analysis of vast datasets, enhancing target identification, compound screening, and drug repurposing efforts.[233.1] The application of AI/ML in clinical neuropharmacology is expected to streamline the drug development process, addressing the high attrition rates and long timelines traditionally associated with central nervous system (CNS) drug development.[235.1]In this section:
References
[1] Introduction to Neuropharmacology | PPT - SlideShare — This document provides an overview of neuropharmacology. It begins by defining neuropharmacology as the study of how drugs affect cellular function in the nervous system and influence behavior. It then discusses neuropharmacological agents and divides them into central and peripheral nervous system drugs. The document outlines the main branches
[2] Neuropharmacology - Wikipedia — Neuropharmacology is the study of how drugs affect function in the nervous system, ... Overview. Neuropharmacology is a very broad region of science that encompasses many aspects of the nervous system from single neuron manipulation to entire areas of the brain, spinal cord, and peripheral nerves.
[3] Neuropharmacology | Brain and Cognitive Sciences - MIT OpenCourseWare — The neuropharmacology course will discuss the drug-induced changes in functioning of the nervous system. The specific focus of this course will be to provide a description of the cellular and molecular actions of drugs on synaptic transmission. This course will also refer to specific diseases of the nervous system and their treatment in addition to giving an overview of the techniques used for
[4] Neuropharmacology - an overview | ScienceDirect Topics — VII Summary. This article has explored neuropharmacology from the standpoint of the most important clinical conditions in the fields of psychiatry, neuropsychiatry, and neurology. Neuropharmacology contributes to these fields by bringing to bear the models of receptor-ligand interactions as one basis for the diseases upon which they focus.
[5] CHAPTER 1: Basic Principles of Neuropharmacology - McGraw Hill Medical — Neuropharmacology is the scientific study of the effects of drugs on the nervous system. Its primary focus is the actions of medications for psychiatric and neurologic disorders as well as those of drugs of abuse. Neuropharmacology also uses drugs as tools to form a better understanding of normal nervous system functioning. The goal of
[8] Pharmacotherapeutic Principles of Neurological and Psychiatric ... — The pharmacotherapeutic management of neurological and psychiatric disorders relies primarily on the modulation of central nervous system (CNS) neurotransmission with drugs that intervene at chemical synapses. The receptors, transporters, and enzymes for the
[11] Questions to Consider When Evaluating Adverse Effects of Psychotropic ... — Evaluating side effects can be particularly hard in mental health settings because psychiatric symptoms often color the presentation of possible side effects and vice-versa. High rates of medical and substance use comorbidity in people with serious psychiatric disorders can confuse even well-trained mental health professionals.
[12] Risk-Benefit Analyses in Medication Decision Making - Psychiatric News — For both patients and practitioners, adverse drug effects—whether actual or imagined—are high on the list of reasons for avoiding psychotropic medications. While the adage may ring true that the cure shouldn't be worse than the disease, optimal treatments often demand a careful assessment of the balance between risks and benefits.
[13] Serotonin and Addiction: The Role of Neurotransmitters in Substance ... — Dopamine, a neurotransmitter linked to pleasure and reward, is closely associated with addiction. When drug use or addictive behaviors occur, it causes intense feelings of pleasure. This is what drives individuals to continue their addictive habits. Another important neurotransmitter is serotonin. It regulates mood, sleep, and appetite.
[14] Substance Abuse: The Interplay Between Dopamine and Serotonin in ... — Dopamine and serotonin are two important neurotransmitters that have key roles in controlling mood and emotional health, affecting how we feel pleasure and happiness. Research indicates that when dopamine and serotonin levels are not balanced, it can lead to different mental health issues, emphasizing the importance of these neurotransmitters in managing happiness. Studies show that people with issues like functional constipation have changed levels of dopamine and serotonin metabolites, linking gut health to emotional conditions ((Chojnacki J et al., 2024)). Knowing how neurotransmitters like dopamine and serotonin connect to feelings of pleasure and happiness is key to understanding human emotion. The balance of neurotransmitters like dopamine and serotonin is very important for well-being, greatly affecting a person’s emotional and mental health.
[16] The role of dopamine in human addiction: From reward to motivated ... — In the last decades, there has been a serious debate on the role of dopamine in addiction (Robinson and Berridge, 1993, Wise, 2004a, Wise, 2004b), but it is now generally accepted that dopamine is pivotal in the development and persistence of addiction.However, its precise role is far from clear. Several studies have shown that dopamine is important in experiencing reward and in motivational
[21] Pharmacokinetics and Pharmacodynamics: Core Principles and Interactions ... — Explore the core principles and interactions of pharmacokinetics and pharmacodynamics in drug absorption, metabolism, receptor binding, and dose-response.
[23] Neurotransmitter interactions in psychotropic drug action: beyond ... — Cholinergic systems, often discussed in the context of unwanted side effects of drugs used in psychiatry, are of obvious importance in relation to cognition and the regulation of sleep. The list of players in the regulation of behaviour is increasingly lengthy and, of course, includes excitatory and inhibitory amino acids such as glutamate and
[48] Neuropharmacology - an overview | ScienceDirect Topics — The field of neuropharmacology emerged essentially in the 1940s and 1950s from the field of pharmacology and the awareness among researchers of internerve communication, and the subsequent isolation of neurotransmitters (Amin and Crawford, 1954; Wrobel, 2007). Although certainly this stems from a much, much, much older practice of attempting to
[50] Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in ... — Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders - PubMed Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) are two widely used neuroimaging techniques to review changes in brain activity. Recent advances in fMRI technology, its application to studying brain function, and the impact of neuroimaging techniques on neuroscience research are discussed. Neuroimaging techniques such as fMRI (A) and EEG (B) have revolutionized our understanding of brain function and have become essential tools in studying neurological disorders.
[51] Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in ... — According to the content of the Review, the following are some relevant keywords that can be used to conduct a literature search related to neuroimaging and its applications: neuroimaging, brain function, neurological diseases, fMRI, EEG, MRI, brain activity, neuro concussion, DTI, TES, Brain Connectivity, White Matter Tracts, Schizophrenia, Chronic Pain, ASD, ADHD, AD, PD, tDCS, Diagnostic Strategies, and Treatment Strategies. Multimodal imaging: Combining fMRI with other imaging techniques, such as EEG and MEG, can provide a more comprehensive understanding of brain activity, allowing researchers to study both the brain function’s spatial and temporal dynamics . 136.Wong P.L., Yang Y.R., Huang S.F., Fuh J.L., Chiang H.L., Wang R.Y. Transcranial Direct Current Stimulation on Different Targets to Modulate Cortical Activity and Dual-Task Walking in Individuals with Parkinson’s Disease: A Double Blinded Randomized Controlled Trial.
[52] MRI in CNS Drug Development - SpringerLink — There are three ways in which magnetic resonance imaging is typically used in drug development: to validate the role of drugs and neuropharmacological systems in terms of their effects on the brain, the development of brain markers to evaluate drugs—these can be associated with particular disorders or symptoms—and the evaluation of compounds with neuroimaging markers.
[54] Medicine and psychiatry in Western culture: Ancient Greek myths and ... — While many ancient cultures have contributed to our current knowledge about medicine and the origins of psychiatry, the Ancient Greeks were among the best observers of feelings and moods patients expressed towards medicine and toward what today is referred to as 'psychopathology'. While Ancient Greeks generally considered psychic and somatic conditions as different manifestations, possibly part of the same illness, in the following centuries physicians often neglected these observations, mainly due to new religious influences. Even if today a scientific approach to medicine, psychiatry and drug therapy is the leading one, ancient medicine and related myths represent a useful tool to enhance compliance and clinical outcome, and should therefore be known by a higher number of medical practitioners, especially by psychiatrists.
[55] Ancient Medicine: How Did Ancient Civilizations Heal Themselves? — One of the foremost ancient civilizations, Ancient Egypt, had a rather impressive understanding of early medicine and the human body. They had a natural understanding of some more common ailments, and connected these closely with their religious beliefs, thinking in many cases that they were caused by harmful demons or ghosts.
[56] Medicine and Health in the Ancient World | EBSCO — Peri ieres noysoy (fifth or fourth century b.c.e.; On the Sacred Disease, 1849) argues that epilepsy is not a divine affliction but may be naturally explained; phlegm blocking the veins that lead to the brain causes paralysis and seizure. Inconsistent ideas, applied medically, are syncretized in the Classic of Internal Medicine, not the work of Huangdi, but originally a heterogeneous assemblage of eighty-one essays, the earliest of which may date to the second century b.c.e. These foundational conceptions are complex and can be set forth here only in a drastically simplified way. By about the fifth century b.c.e., a confluence of Vedic practices, other forms of folk medicine, and above all Buddhism and Yoga lead to the development of Ayurveda, the science of longevity.
[57] The Ancient Greek discovery of the nervous system: Alcmaeon, Praxagoras ... — The Ancient Greek discovery of the nervous system: Alcmaeon, Praxagoras and Herophilus - ScienceDirect The Ancient Greek discovery of the nervous system: Alcmaeon, Praxagoras and Herophilus This discovery is central not only to neuroscience, but also to all of medicine and to our concept of the human organism: it articulated the connection between the mind, the brain, and the body. Physician–philosophers such as Alcmaeon, and, in later centuries physicians such as Praxagoras and Herophilus, attempted to understand the biological form and function of the brain, and its relationship to the rest of the body .
[58] Ancient Neurological Treatments: Insights from Early Civilizations — By integrating scientific inquiry with practical treatment, Galen’s contributions to brain treatment remain a vital part of ancient neurological treatments, reflecting the sophisticated understanding of health in antiquity. These holistic methods underscored a comprehensive approach to health, recognizing the interconnectedness of the mind and body in ancient neurological treatments. These ancient neurological treatments reflect a deep understanding of human health that extends beyond mere symptoms, focusing instead on comprehensive healing practices that are still relevant today. The methods used in ancient Indian approaches to neurology include individualized treatment plans that incorporate lifestyle adjustments, herbal remedies, and therapeutic practices. Spirituality has profoundly influenced ancient neurological treatments, integrating the mind, body, and spirit in healing practices. Ancient neurological treatments exhibit significant contrasts and similarities with modern practices, reflecting the evolution of medical understanding over centuries.
[59] Neuropharmacology | Journal of Neurological Research And Therapy — One area of focus for neuropharmacology research is the treatment of neurological disorders such as Parkinson's disease, Alzheimer's disease, and epilepsy. Treatments for these conditions typically involve targeting specific areas of the brain, including dopamine receptors, cholinergic receptors, and gamma-aminobutyric acid (GABA) receptors.
[64] Psychiatric neural networks and neuropharmacology: Selected advances ... — Psychiatric disorders are often considered as simple imbalances between a limited number of cerebral neurotransmitters. ... These results constitute advances in neuropharmacology by illustrating how 5-HT1A receptors in amygdale constitute a potential target for anxiolytic drugs and a therapeutical research key in anxiety behavior area whereas
[65] The Impact of Psychopharmacology on Contemporary Psychiatry — Moreover, their impact extended far beyond improvements in treatment, and included fundamental changes in the conceptualization of most psychiatric disorders, in their diagnosis and categorization, on models for research into the nature of psychiatric illnesses, on psychiatric education, on methods and standards for experimental therapeutics, and on the organization of modern psychiatry as a clinical and academic medical specialty. In addition, evidence for long-term effectiveness of most types of psychotropics in providing sustained benefits and protection from recurrences of psychiatric illnesses remains particularly limited and often based on ambiguous research methods.1 These include the potentially biasing selection of patients who respond, short term, to a given drug-product (whose manufacturer typically sponsors the trial) to continue (relatively briefly in comparison to the natural history of recurrence patterns) into aftercare that often involves randomized discontinuation to a placebo—that is, removing an apparently effective treatment, often with incomplete recovery from an acute illness.
[66] Neuropharmacology - Neuroscience for Newbies — In the morning, a neuropharmacologist might work in the lab, testing how new drug compounds interact with specific receptors or neurotransmitter systems in the brain. Neuropharmacologists must be skilled in designing experiments to test how drugs affect the brain and behavior. Many neuropharmacologists are involved in drug development, which requires knowledge of the drug discovery process, including lead compound identification, preclinical testing, and clinical trial design. Neuropharmacologists may also work in pharmaceutical companies, where they develop new treatments, or in academic research labs, where they study how drugs affect the nervous system. By understanding how drugs interact with the brain’s chemical signaling pathways, neuropharmacologists can design new medications that alleviate symptoms, improve quality of life, and help people manage complex conditions like depression, schizophrenia, and Parkinson’s disease.
[91] What Are the Latest Advances in Neuropharmacology for Neurological ... — Advances in Neuropharmacology: Novel Drug Targets and Therapies for Neurological Disorders Advances in neuropharmacology explore novel drug targets, nanotechnology-based delivery systems for neurological disorders, and more. What Are Novel Drug Delivery Systems, and How Do They Advance Neuropharmacology for Treating Neurological Disorders? In the field of neuropharmacology, gaining insights into novel drug targets for neurological disorders is a fundamental aspect of advancing medical research and treatment strategies. The limitations created by conventional drug delivery techniques are addressed by novel drug delivery systems, which represent inventive methods to efficiently and precisely target medications to specific regions within the brain. Gaining insights into novel drug targets is crucial to advancing neuropharmacology and finding effective treatments for neurological disorders.
[93] What Are the Latest Advances in Neuropharmacology for ... - iCliniq — 1. Neurotransmitter Systems: Neuropharmacological therapies have long been centered on classic neurotransmitter systems like serotonin, dopamine, and acetylcholine. However, a more in-depth study of these systems has revealed particular serotonin receptor subtypes that may be crucial for mood regulation and cognition.
[94] Chapter 19 - Neuropharmacology and neurotherapeutics - ScienceDirect — It encompasses the comprehensive examination of neurotransmitters, receptors, signaling pathways, and the intricate processes involved in drug development. Recent years have witnessed remarkable advancements in the fields of molecular and cellular neuroscience, significantly augmenting our understanding of the intricacies of the brain.
[97] New and emerging approaches to treat psychiatric disorders — Deep brain stimulation (DBS) enables the direct modulation of deeper (subcortical) structures with the highest spatial and temporal precision and holds tremendous potential for the treatment of psychiatric disorders because it enables precise modulation of activity at any node along a dysfunctional circuit. Additional open-label trials targeting the SCC14 or ventral capsule–ventral striatum (VC/VS)15 (a region innervated with dopaminergic neurons known to be involved in reward processing and error prediction) showed similar effects and led to excitement at the prospect of treating major depressive disorder (MDD) by reversing dysfunctional brain activity. One recent study performed electrical stimulation mapping of brain function (Table 1) before DBS implantation to uncover dysfunctional circuit activity underlying core depression symptoms at the individual level.
[98] New and emerging approaches to treat psychiatric disorders — New and emerging approaches to treat psychiatric disorders - PubMed Search in PubMed Search in PubMed Although their etiological and diagnostic heterogeneity has long challenged drug discovery, an emerging circuit-based understanding of psychiatric illness is offering an important alternative to the current reliance on trial and error, both in the development and in the clinical application of treatments. Here we review new and emerging treatment approaches, with a particular emphasis on the revolutionary potential of brain-circuit-based interventions for precision psychiatry. Major circuits and neurotransmitter pathways that are disrupted in a wide range of psychiatric disorders and that represent targets for treatment, based on extant knowledge. Search in PubMed Search in PubMed Search in PubMed Search in PubMed Search in PubMed
[99] Recent Advances in Nanotherapeutics for Neurological Disorders — therapeutics. Nanotechnology has proven its potential to improve therapeutic delivery and enhance efficacy.Promising advancements have been made in developing nanotherapies that can be combined with CRISPR/Cas9 or siRNA for a targeted approach with unique potential for clinical translation. Engineering natural exosomes
[130] Basic principles of neuropharmacology - Nurse Key — The effects of neuropharmacologic drugs, like those of neurons, depend on altering receptor activity. That is, no matter what its precise mechanism of action, a neuropharmacologic drug ultimately works by influencing receptor activity on target cells. This commonsense concept is central to understanding the actions of neuropharmacologic drugs.
[131] PDF — n3 major steps in neuron action: -Conduction of action potential -Release of neurotransmitter from axon -Binding of transmitter molecules to receptors on post-synaptic cell nAction at synapse level -Most neuropharmacologic agents act at synapse transmission level • Axonal conduction NOT a common site of action
[140] Neuropharmacology - Wikipedia — Neuropharmacology is the study of how drugs affect ... Neurotransmitter/receptor interactions in the field of neuropharmacology are extremely important because many drugs that are developed today have to do with disrupting this binding process. Molecular neuropharmacology. Molecular neuropharmacology involves the study of neurons
[141] Drug and neurotransmitter receptors in the brain - PubMed — Biochemical investigation of receptors for neurotransmitters and drugs in the brain has been one of the most active areas of molecular neuroscience during the past decade. This work has permitted fundamental insights into how binding of neurotransmitters to their receptors excites or inhibits neuronal firing or changes cellular metabolism.
[142] Neurotransmitters and Their Receptors - 2003 - PMC - PubMed Central (PMC) — Using the procedures of molecular biology, 14 serotonin receptors have been found so far (if the author has not missed some data). In the 1990s, new drugs acting on particular 5-HT receptors were developed. Buspirone, gepirone and ipsapirone are new anxiolytics, partial 5-HT 1A receptor agonists, with slow onset of action.
[143] PDF — Drug-receptor interactions play a pivotal role in the field of pharmacology and drug development, influencing the eficacy and safety of therapeutic agents. These interactions involve the binding of drugs to specific molecular targets, known as receptors, which are located on the surface or within cells.
[171] Neuropharmacology - SpringerLink — Neuropharmacology is influenced by progress in every area of biology and medicine. The increasing interest in the effects of growth factors and cytokines in the nervous system has led to the investigation of whether some of these endogenous molecules, or their synthetic derivatives, might be of use in the treatment of neurological disease (see chapter on Growth Factors).
[177] Patient-Centered Approaches In Pharma: From R&D to the Future — Future Outlook: The future of patient-centered approaches in the pharmaceutical industry is promising, with ongoing efforts to integrate patient voices at every stage of drug development and healthcare delivery. Collaborative initiatives between pharmaceutical companies, healthcare providers, regulators, and patient advocacy groups will likely
[184] The Evolution of Mental Health Treatment and Its Impact on Society — The Evolution of Mental Health Treatment and Its Impact on Society – Science Technology and Society a Student Led Exploration Riley Karsen Lovelace; Nick Allan Rodgers; Leah C Chappell; Liam Dennis Wood; Cole Thomas Gaccione; Morgan Breanna Reeves; Caleb Eickhoff; Nick Sanborn; Elizabeth K Bland; Giulia Emanuel; and Patrick James Orr The Evolution of Mental Health Treatment and Its Impact on Society developments as led by pioneers like Philippe Pinel and William Tuke resulted in the development of more humane approaches to treating mental illness by the 19 th century (Greenberg, 2013; National Institute of Mental Health, 2023). Development in treating mental health encompasses talk therapy which emerged in the late 19 th century as Sigmund Freud worked with children with learning disabilities (Marks, 2017).
[186] The Evolution of Mental Health: How It Has Changed Over Time — From ancient beliefs and stigmatization to modern advancements in psychopharmacology and evidence-based therapies, this article explores how our understanding of mental health has changed over time. Discover how early medical approaches and the rise of psychoanalysis shaped the field, and how deinstitutionalization and community-based care have transformed the way we address mental health. – Evidence-based therapies, incorporating scientific research and personalized approaches, have emerged as effective treatments for mental health conditions. With the shift towards deinstitutionalization and community-based care, advancements in psychopharmacology have played a crucial role in improving the treatment and management of mental health conditions. These advancements in therapy techniques and the integration of evidence-based practices have greatly improved the effectiveness of mental health treatments, providing hope and better outcomes for individuals seeking help.
[187] Understanding Mental Health: A Historical Perspective from Different ... — Understanding Mental Health: A Historical Perspective from Different Time Periods Understanding Mental Health: A Historical Perspective from Different Time Periods Mental Health Mental Health October 17, 2023 by Brain Spa 6Likes The 19th century witnessed significant advancements in our understanding of mental health. Progress and Advancements: Transforming Mental Health Care Today One significant development has been the increased understanding and recognition of mental health conditions as legitimate medical disorders. Our historical journey through the evolution of mental health understanding demonstrates how far we have come in our comprehension and treatment of mental illnesses. Today, mental health is rightly recognized as a crucial aspect of overall well-being, and efforts continue to improve access to care and reduce the stigma associated with mental illnesses. Mental Health
[188] Chapter 1 - Historical Perspectives on Mental Health and Psychiatry — From only a dozen such organisations in the 1980s, there were more than 500 by 2005, partly due to the establishment of the NHS and the Community Care Act of 1990.28 By banding together, the families of people designated ‘mentally ill’ could share information, provide encouragement and lobby for improved facilities.29 In 1970, a major battle was won when the government passed the Education (Handicapped Children) Act, which gave all children with disabilities the right to education.
[189] Neurotransmitters and Their Receptors - 2003 - PMC — In addition, some of the same subunits that form GABA-A receptor in particular regions of the brain will form a glycine receptor with substantially different pharmacologic properties. It has been demonstrated that certain drugs with quite specific and known actions on particular neurotransmitter receptors can considerably modify neurogenesis and thus probably also brain plasticity. The few recent studies of the management of nonketotic hyperglycaemia, a rare metabolic disease characterized by an increased level of glycine in CSF and serum, and neurologically by motor dysfunction, indicate that besides strychnine, the use of dextromethorphan and ketamine (NMDA receptor blockers) that also possess a binding site for glycine, is therapeutically efficient; however, the physiologic role of this receptor differs substantially from that of glycine.
[190] Neurotransmission: Neurotransmitters, Receptors, and Neuropharmacology — The exact number of unique neurotransmitters in humans is unknown, but hundreds have been identified and many more are likely still to be discovered. More excitingly, the pharmacology of neurotransmission—from the neurotransmitter to the receptor—is of both scientific and clinical interest as well.
[191] Neuropharmacology and neurotherapeutics: Advancing the understanding ... — It encompasses the comprehensive examination of neurotransmitters, receptors, signaling pathways, and the intricate processes involved in drug development. Recent years have witnessed remarkable advancements in the fields of molecular and cellular neuroscience, significantly augmenting our understanding of the intricacies of the brain.
[192] Neuropharmacology - Neuroscience for Newbies — In the morning, a neuropharmacologist might work in the lab, testing how new drug compounds interact with specific receptors or neurotransmitter systems in the brain. Neuropharmacologists must be skilled in designing experiments to test how drugs affect the brain and behavior. Many neuropharmacologists are involved in drug development, which requires knowledge of the drug discovery process, including lead compound identification, preclinical testing, and clinical trial design. Neuropharmacologists may also work in pharmaceutical companies, where they develop new treatments, or in academic research labs, where they study how drugs affect the nervous system. By understanding how drugs interact with the brain’s chemical signaling pathways, neuropharmacologists can design new medications that alleviate symptoms, improve quality of life, and help people manage complex conditions like depression, schizophrenia, and Parkinson’s disease.
[198] Individualized psychiatric care: integration of therapeutic drug ... — Personalized treatment optimization integrates therapeutic drug monitoring, pharmacogenomics, and biomarker testing to enhance pharmacotherapy for major psychiatric disorders. Individual clinical, genetic, and environmental factors significantly influence drug efficacy and tolerability in psychiatric treatment.
[199] Pharmacogenomics Genetic Compatibility to Medications — The efficacy of pharmacogenomic testing in mental health treatment has far-reaching implications, particularly in light of the increasing burden of mental health disorders on public health systems. By incorporating genomics into the treatment process at NRI, there exists an opportunity to promote smarter, more sustainable healthcare solutions.
[206] What Are the Latest Advances in Neuropharmacology for Neurological ... — Advances in Neuropharmacology: Novel Drug Targets and Therapies for Neurological Disorders Advances in neuropharmacology explore novel drug targets, nanotechnology-based delivery systems for neurological disorders, and more. What Are Novel Drug Delivery Systems, and How Do They Advance Neuropharmacology for Treating Neurological Disorders? In the field of neuropharmacology, gaining insights into novel drug targets for neurological disorders is a fundamental aspect of advancing medical research and treatment strategies. The limitations created by conventional drug delivery techniques are addressed by novel drug delivery systems, which represent inventive methods to efficiently and precisely target medications to specific regions within the brain. Gaining insights into novel drug targets is crucial to advancing neuropharmacology and finding effective treatments for neurological disorders.
[216] What Are the Latest Advances in Neuropharmacology for ... - iCliniq — Advances in Neuropharmacology: Novel Drug Targets and Therapies for Neurological Disorders Advances in neuropharmacology explore novel drug targets, nanotechnology-based delivery systems for neurological disorders, and more. What Are Novel Drug Delivery Systems, and How Do They Advance Neuropharmacology for Treating Neurological Disorders? In the field of neuropharmacology, gaining insights into novel drug targets for neurological disorders is a fundamental aspect of advancing medical research and treatment strategies. The limitations created by conventional drug delivery techniques are addressed by novel drug delivery systems, which represent inventive methods to efficiently and precisely target medications to specific regions within the brain. Gaining insights into novel drug targets is crucial to advancing neuropharmacology and finding effective treatments for neurological disorders.
[218] Exploring Novel Molecular Targets for Alzheimer's Disease in ... — Alzheimer's disease (AD) remains a formidable neurodegenerative challenge, characterized by profound cognitive decline. Despite decades of research, effective disease-modifying therapies are elusive. Recent advances in molecular neuropharmacology have unveiled potential therapeutic targets for AD, offering renewed hope. Method
[219] Neuropharmacology - an overview | ScienceDirect Topics — Future Directions. Neuropeptides represent a highly active area of research in neurobiology and neuropharmacology, and much of the data listed above probably need to be updated in the light of the emerging roles of glial cells in the physiology and pathology of the nervous system. Moreover, there is increasing evidence that GPCRs are present in
[223] The future of neurotechnology innovation - ScienceDirect — Advances across several areas of neurotechnology research including stem cells treatments, new imaging technologies, drug delivery technologies and novel neuromodulation platforms promise to accelerate the development of treatments and cures for brain-related illnesses.
[224] The grand challenge at the frontiers of neurotechnology and its ... — The OECD has identified, five possible systemic changes that could help speed up neurotechnology developments to meet pressing health challenges and societal needs while also ensuring this is undertaken responsibly and that the necessary safeguards are in place (22): (1) responsible research (this encourages consideration of ethical, legal and social issues ([ELSI] and collaboration between all stakeholders, including patients, patient organizations and funders, throughout the development process), (2) anticipatory governance (as discussed earlier, proactive consideration of ELSI so that frameworks can be put in place in good time), (3) open innovation (in light of the investment risks and high failure rates of clinical trials, neurotechnology companies could take an open innovation approach in which public and private stakeholders collaborate, invest, and share assets), (4) avoiding neuro-hype (controlling unproven claims and myths about neurotechnology and being realistic about what it can achieve by means of evidence-based policies and guidelines for its responsible development and use), and (5) access and equity (addressing socioeconomic questions and ensuring access to innovation in resource-limited countries.
[226] Nanotechnology in the Prevention and Treatment of Neurological Disorders — Nanotechnology is an actively developing science and has its branches in many fields of science and technology. The delivery of drugs to the central nervous system (CNS) for the treatment of motor disorders and their passage through the blood-brain barrier (BBB) represents a significant challenge. There are active developments in the field of movement disorders, but one of the most
[228] Translational challenges in advancing regenerative therapy for treating ... — In this review, we discuss current regenerative therapies for neurological diseases, nanotechnology as nanocarriers, and the technical, manufacturing, and regulatory challenges that arise from inception to formulation of nanoparticle-regenerative therapies.
[230] Neuro-nanotechnology: diagnostic and therapeutic nano-based strategies ... — One of the benefits of advances in nanotechnology is its ability to increase the specificity of complicated biological systems while also decreasing unwanted side effects . These changes will have a large influence on neuroscience, particularly by allowing for the development of more effective and targeted therapies.
[233] Artificial intelligence and machine learning‐aided drug discovery in ... — After introducing the AI/ML models as well as the conceptualization and data preparation, we outline the applications of AI/ML technologies to several key procedures in drug discovery, including target identification, compound screening, hit/lead generation and optimization, drug response and synergy prediction, de novo drug design, and drug repurposing. In drug discovery studies for schizophrenia, researchers have utilized AI/ML methods with various purposes, including drug target identification, 363 , 364 developing QSAR models, 365 predicting monitoring dosing compliance, 366 predicting GPCRs targeting compounds, 364 and drug repositioning. 378 In the next study of Chekroud et al., 381 they clustered the symptoms using an unsupervised learning approach (hierarchical clustering) and predict the responsiveness of each cluster to the treatment of different antidepressant drugs using the same model in the previous study.
[235] Artificial intelligence and machine learning-aided drug discovery in ... — Neurological disorders significantly outnumber diseases in other therapeutic areas. However, developing drugs for central nervous system (CNS) disorders remains the most challenging area in drug discovery, accompanied with the long timelines and high attrition rates. With the rapid growth of biomedi …
[258] The challenges of personalised medicine - 2021 - Prescriber - Wiley ... — To date, there are significant barriers to widespread implementation of personalised medicine in general practice - in particular, reflecting our lack of a sufficient understanding of the pathophysiology of many common diseases (depression and epilepsy immediately spring to mind), as well as of the mechanism by which many of the drugs we use
[259] PDF — Challenges, Opportunities and Facilitators in Implementing Personalised Medicine Content Abstract 2 Introduction and Main Key Points 2 Results 4 Engaging relevant stakeholders in the implementation process of personalised medicine 4 Engaging Patients and Citizens 5 Engaging Policy Makers 5 Engaging Healthcare Professionals 6 Collaboration between relevant stakeholders during the implementation process of personalised medicine 7 Establishment of a national or regional common strategy 7 Infrastructure needed during the implementation process of personalised medicine 8 Information Technology and Data Management Systems 8 Biobanks 9 Genomic and Molecular Diagnostics 9 Platforms for Patient Engagement 9 Education and training in personalised medicine 9 Healthcare Professionals 10 Medical Laboratory Technicians and IT Specialists 10 Researchers 11 Patients and citizens 11 Resource allocation during the implementation process of personalised medicine 11 Financial resources 11 Logistical resources 12 Human resources 12 Regulations and legislations for personalised medicine approaches 12 Ethical considerations 13 Discussion 13 Conclusion 14 Impress 15 2 Abstract Background In 2019, the International Consortium for Personalised Medicine (ICPerMed) has developed a vision of how the use of personalised medicine (PM) approaches will promote "next-generation" medicine in 2030, more firmly centred on the individual’s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation and imple mentation for the benefit of patients, citizens, and society.
[260] Personalized medicine: motivation, challenges, and progress — challenges associated with personalized disease prevention, personalized health monitoring, and personalized treatment of overt disease. ... In fact, practical issues surrounding the implementation of personalized medicine that Hogben and Sim considered are often overlooked in contemporary discussions about person-
[261] The Roadmap toward Personalized Medicine: Challenges and Opportunities ... — In 2019, the International Consortium for Personalised Medicine (ICPerMed) developed a vision on how the use of personalized medicine (PM) approaches will promote “next-generation” medicine in 2030 more firmly centered on the individual’s personal characteristics, leading to improved health outcomes within sustainable healthcare systems through research, development, innovation, and implementation for the benefit of patients, citizens, and society. country population) have different needs for implementation (e.g., mobile phone connection and telemedicine organization) | Health and care access and digital health integration | Healthcare providers, government authorities, healthcare regulators, policy makers, patient advocacy groups, technology providers, telecommunication companies |
[262] Personalized Medicine: Motivation, Challenges and Progress — These extreme genetic variation explains, in part, why individuals vary so much with respect to phenotypes, in particular their susceptibilities to disease and their responses to interventions.(13) It should be emphasized that although personalized medicine has its roots in the results of genetic studies, it is widely accepted that other factors, e.g., environmental exposures, developmental phenomena and epigenetic changes, and behaviors, all need to be taken into account when determining the optimal way to treat an individual patient (see Figure 1).(14-16) These activities include the use of patient-derived cell and organoid ‘avatars’ for determining the best therapies for that patient, the use of intense individualized diagnostic and monitoring protocols to detect signs of disease, the development of personalized digital therapeutics, and the use of personalized medicine approaches in treating patients with fertility issues.
[263] Toward personalized medicine in the neuropsychiatric field — Toward personalized medicine in the neuropsychiatric field - PubMed Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Your saved search Name of saved search: Add to Search Add to Search Advances in human genome science and molecular innovations in neuroscience have encouraged the pharmaceutical industry to focus beyond broad spectrum population therapeutics--the driving force behind the "blockbuster" product concept--to personalized medicine. Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Add to Search Precision Medicine / methods* Add to Search Precision Medicine / trends Add to Search Add to Search Add to Search